We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$52.3B
AUM Growth
+$4.34B
Cap. Flow
-$146M
Cap. Flow %
-0.28%
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79

Top Buys

Rank Stock Value
1
IS
ironSource Ltd.
IS
+$136M
2
TSLA icon
Tesla
TSLA
+$119M
3
VZ icon
Verizon
VZ
+$109M
4
HD icon
Home Depot
HD
+$101M
5
PFE icon
Pfizer
PFE
+$88M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$247M
2
INTC icon
Intel
INTC
+$216M
3
F icon
Ford
F
+$145M
4
GM icon
General Motors
GM
+$143M
5
MU icon
Micron Technology
MU
+$125M

Sector Composition

Rank Sector Weight
1 Technology 25.15%
2 Healthcare 14.97%
3 Financials 14.22%
4 Consumer Discretionary 11.15%
5 Communication Services 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALX icon
1576
Calix
CALX
$2.34B
$567K ﹤0.01%
+7,090
New +$463K
EQC
1577
DELISTED
Equity Commonwealth
EQC
$567K ﹤0.01%
+21,880
New +$570K
MEI icon
1578
Methode Electronics
MEI
$525M
$566K ﹤0.01%
11,507
-20,710
-64% -$932K
VRTV
1579
DELISTED
VERITIV CORPORATION
VRTV
$566K ﹤0.01%
4,616
-10,850
-70% -$1.31M
FBK icon
1580
FB Financial Corp
FBK
$2.98B
$565K ﹤0.01%
12,900
SHOE
1581
Shoe Station Group
SHOE
$431M
$565K ﹤0.01%
14,470
-12,530
-46% -$471K
SUPN icon
1582
Supernus Pharmaceuticals
SUPN
$2.77B
$564K ﹤0.01%
19,346
-30,740
-61% -$933K
VREX icon
1583
Varex Imaging
VREX
$469M
$564K ﹤0.01%
17,875
-15,530
-46% -$440K
MODV
1584
DELISTED
ModivCare
MODV
$563K ﹤0.01%
3,794
-7,940
-68% -$1.23M
OXM icon
1585
Oxford Industries
OXM
$613M
$563K ﹤0.01%
5,545
-9,420
-63% -$916K
CDLX icon
1586
Cardlytics
CDLX
$22.3M
$562K ﹤0.01%
+850
New +$650K
BMBL icon
1587
Bumble
BMBL
$393M
$561K ﹤0.01%
+16,580
New +$705K
CERT icon
1588
Certara
CERT
$1.23B
$560K ﹤0.01%
+19,690
New +$662K
EGBN icon
1589
Eagle Bancorp
EGBN
$866M
$559K ﹤0.01%
9,590
-14,810
-61% -$857K
AZZ icon
1590
AZZ Inc
AZZ
$4.41B
$556K ﹤0.01%
10,060
-15,140
-60% -$822K
MTEM
1591
DELISTED
Molecular Templates, Inc.
MTEM
$552K ﹤0.01%
9,384
+2,365
+34% +$177K
ADUS icon
1592
Addus HomeCare
ADUS
$2.23B
$550K ﹤0.01%
5,880
-5,320
-48% -$478K
BILI icon
1593
Bilibili
BILI
$7.56B
$550K ﹤0.01%
11,850
TREE icon
1594
LendingTree
TREE
$572M
$547K ﹤0.01%
4,460
-3,240
-42% -$431K
BDN
1595
Brandywine Realty Trust
BDN
$521M
$544K ﹤0.01%
40,500
SHEN icon
1596
Shenandoah Telecom
SHEN
$655M
$541K ﹤0.01%
21,220
-11,280
-35% -$317K
TALO icon
1597
Talos Energy
TALO
$2.28B
$541K ﹤0.01%
55,170
+8,570
+18% +$97.7K
CAL icon
1598
Caleres
CAL
$447M
$540K ﹤0.01%
23,790
-26,310
-53% -$628K
MLAB icon
1599
Mesa Laboratories
MLAB
$559M
$538K ﹤0.01%
1,640
-1,960
-54% -$615K
UNM icon
1600
Unum
UNM
$14B
$536K ﹤0.01%
21,800

Similar funds

Ensign Peak Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
  • Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
  • Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
  • Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
  • Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
  • Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
  • Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.

Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.